NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 116 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510,647 | -78.0% | 477,240 | -46.9% | 0.00% | – |
| Q2 2023 | $2,326,163 | -33.4% | 898,132 | +4.9% | 0.00% | – |
| Q1 2023 | $3,493,740 | +5.1% | 856,309 | +29.3% | 0.00% | – |
| Q4 2022 | $3,323,406 | -53.6% | 662,033 | +21.0% | 0.00% | -100.0% |
| Q3 2022 | $7,155,000 | -5.6% | 547,059 | -7.5% | 0.00% | 0.0% |
| Q2 2022 | $7,579,000 | -14.4% | 591,224 | +1.8% | 0.00% | 0.0% |
| Q1 2022 | $8,855,000 | +70.1% | 580,704 | +97.5% | 0.00% | 0.0% |
| Q4 2021 | $5,206,000 | +73.5% | 293,967 | +105.9% | 0.00% | – |
| Q3 2021 | $3,000,000 | -8.8% | 142,748 | -14.4% | 0.00% | – |
| Q2 2021 | $3,289,000 | -53.4% | 166,775 | -31.2% | 0.00% | -100.0% |
| Q1 2021 | $7,052,000 | +10.7% | 242,570 | +15.4% | 0.00% | 0.0% |
| Q4 2020 | $6,371,000 | +161.6% | 210,283 | +37.4% | 0.00% | – |
| Q3 2020 | $2,435,000 | -33.5% | 153,049 | -17.5% | 0.00% | -100.0% |
| Q2 2020 | $3,662,000 | +10362.9% | 185,521 | +6326.1% | 0.00% | – |
| Q1 2020 | $35,000 | -95.9% | 2,887 | -93.7% | 0.00% | – |
| Q4 2019 | $846,000 | +181.1% | 45,751 | +110.6% | 0.00% | – |
| Q3 2019 | $301,000 | – | 21,722 | +86788.0% | 0.00% | – |
| Q2 2019 | $0 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 15,396,116 | $303,611,000 | 42.97% |
| Ponoi II Management, LLC | 1,298,908 | $25,614,000 | 20.76% |
| Ponoi Management, LLC | 1,298,908 | $25,614,000 | 14.23% |
| Euclidean Capital LLC | 1,493,349 | $29,449,000 | 9.56% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $74,279,000 | 6.80% |
| Aquilo Capital Management, LLC | 1,194,237 | $23,550,000 | 6.12% |
| Greenspring Associates, LLC | 1,573,357 | $31,027,000 | 2.10% |
| Octagon Capital Advisors LP | 200,000 | $3,944,000 | 0.82% |
| Redmile Group, LLC | 2,792,448 | $55,067,000 | 0.82% |
| BVF INC/IL | 955,000 | $18,833,000 | 0.71% |